Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price.
Seven-day window, 3 weeks back · Material filings: 77 · All filings: 289
Sturm Ruger terminated its shareholder rights plan effective immediately, accelerating expiration from October 13 to September 16, 2026. This follows satisfaction of regulatory conditions under a Strategic Cooperation Agreement with Beretta Holding announced in May.
Generac entered a long-term supply agreement with Amazon, issuing a warrant for up to 1.69M shares at $200.93/share. Initial deliveries expected to total $2.4B in 2027–2028, with vesting contingent on up to $8B in aggregate payments for backup generators for Amazon data centers.
Mercury Systems extended CEO William L. Ballhaus's employment agreement through August 15, 2030. The company reaffirmed prior financial guidance issued on August 18, 2026. No material business changes disclosed.
8-K · Item 2.01 — Acquisition or disposal of assets
BrightSpire completed sale of two industrial net-lease properties (Arizona, California) for $300M gross consideration on September 14, 2026. Transaction generated approximately $60.4M estimated gain and $97.9M net cash proceeds after debt assumption.
Company restructured convertible debt by consolidating notes, eliminating interest through 2028, converting prior accrued interest to equity at $0.10/share, and amending articles to create Class B non-voting shares.
OCSL issued $300M of 7.000% unsecured notes due 2031. Proceeds will reduce senior secured revolving credit facility debt and fund general corporate purposes, including potential repayment of 2027 notes at maturity.
EPRT amended its credit agreement, increasing revolving facility from $1.0B to $1.3B, reducing pricing margins, releasing subsidiary guarantors, and repaying/terminating a Capital One facility.
ChronoScale extended maturity of $2.0M term loan from September 2026 to November 2026 and permitted sale of subsidiary. Extension suggests difficulty meeting original obligations and potential distress.
Tenable completed an $800M convertible notes offering (upsized from $650M), generating ~$779M net proceeds. Funds used to repay term loans, repurchase $170.5M stock, and fund capped call transactions. Provides financial flexibility for acquisitions and strategic investments.
Company amended its equity purchase agreement with Chardan Capital Markets, reducing per-share pricing to 98.5% and 97.0% of VWAP for future share sales after 160M shares sold. This represents dilution and weaker pricing terms.
NFE completed a comprehensive debt restructuring on September 11, 2026, separating into two independent companies (BrazilCo and CoreCo). Terminated debt totaling multiple senior notes and credit facilities; exchanged for new debt, equity, and preferred interests. Significant dilution to existing shareholders.
DigitalOcean secured $725M equipment financing facility (expandable to $1.025B) to fund GPU/CPU infrastructure for AI-Native Cloud platform capacity expansion, with 4-year maturity and attractive cost of capital.
8-K · Items 2.01, 8.01 — Acquisition or disposal of assets
Tarsus completed acquisition of Alkeus Pharmaceuticals, adding gildeuretinol (ALK-001), a Phase 3 oral investigational medicine for Stargardt's disease with Breakthrough Therapy and Orphan Drug designations. NORTHSTAR Phase 3 trial topline data anticipated in 2029.
As stated in the filing: “…Horizon Bancorp, Inc. issued a press release announcing that the Company’s financial results for the third quarter of 2026 will be released after the market close on Wednesday, October 21, 2026.”
As stated in the filing: “…SouthState Bank Corporation (NYSE: SSB) (“SouthState” or the “Company”) announced today that it will release third quarter 2026 earnings results on Wednesday, October 21, 2026, after the market closes.”
Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.
Lindblad acquired 60% controlling interest in Antarctic expedition and aviation companies (White Desert Ltd, PNR Airways Ltd, Echo Charlie Ltd) for ~$61M cash plus ~$6M for balance sheet cash, with options to acquire remaining equity by 2031.
WD amended its Master Repurchase Agreement with JPMorgan Chase Bank, extending the termination date to September 9, 2027. This is the ninth amendment to the facility since 2019, with terms detailed in an updated side letter.
Athena Funding III LLC (Blue Owl subsidiary) amended its loan facility, increasing maximum principal from $150M to $250M and modifying borrowing base conditions. Expansion signals lender confidence and increased capital availability.
ARCC issued $750M of 6.250% unsecured notes due 2033. Proceeds will repay existing credit facility debt; company may reborrow for general corporate purposes and portfolio investments. Interest rate swap entered to convert fixed to floating rate.
Pulse Biosciences entered into a new $85M equity distribution agreement with Mizuho, replacing a prior $75M agreement with TD Cowen. The company has already sold ~$68.8M under the August 2026 agreement, indicating ongoing dilution and capital needs.
HealthStream raised $40.0M via issuance of 1.36M shares at $29.50/share to WJRJJ Ventures. CEO Frist sold 144K shares. Investor has 42% stake in Empath Nursing, with which HealthStream has a strategic partnership. Proceeds for general corporate purposes and potential acquisitions.
Calumet increased its credit facility commitments from $500M to $600M via the Eleventh Amendment to its Credit Agreement, effective September 11, 2026. Related monetization agreement amended to accommodate the expansion.
Iridium amended its credit agreement with lenders to permit the pending Rocket Lab merger to proceed without triggering a change-of-control clause. Post-closing, interest rates will increase and prepayment/exit fees will apply.
Applied Optoelectronics' subsidiary Global Technology leased a 38,312 sq meter manufacturing facility in Ningbo, China for 10 years at RMB 6.9M annual rent, with 3% increases every three years and tenant protections including right of first refusal.
Capital Southwest Corporation issued $350M in 6.750% unsecured notes due 2031, netting ~$342.1M after fees. Proceeds will repay a portion of the senior secured revolving credit facility. Standard debt capital raise with no stated business impact.
Q1 FY2027 net income surged 1530% to $16.3M; diluted EPS up 900% to $0.10. Company completed transformational Sweetwater acquisition, becoming largest U.S. non-precious metal royalty platform with 5.3M acres. Uranium counterparties maintained production guidance.
Trilogy Metals closed a ~$35.6M strategic equity investment from the U.S. Department of War, making the government an ~10% shareholder. Proceeds fund exploration and development of Alaska's Upper Kobuk Mineral Projects, advancing domestic copper supply.
Perdoceo signed definitive agreement to acquire South University for ~$130–150M upfront plus $18M deferred and up to $56M earn-out. South generated ~$291M revenue and $34M adjusted operating income in 2025 with ~10,500 students. Expected close April 2027; transaction expected immediately accretive to adjusted operating income in 2027.
Company amended its ChEF Purchase Agreement with Chardan Capital Markets, adjusting VWAP-based pricing terms for potential future share sales. VWAP Purchase price set at 98.5% of VWAP; Off-Hour VWAP Purchase at 97.0%.
8-K · Items 1.01, 2.01, 3.02, 8.01 — Material agreement
Ondas acquired GATE Technologies and Bron Technologies for $205M upfront plus up to $185M earn-out. GATE develops electronic safe-and-arm devices and fuzing technology for missiles, rockets, UAVs and loitering munitions. Expected to generate $130M+ Adjusted EBITDA through 2028.
CubeSmart filed an 8-K furnishing a September 2026 investor presentation. The document provides corporate overview, historical performance metrics, portfolio composition, operational strategies, and governance practices. No material business developments, earnings results, or operational changes are disclosed.
Veracyte completed acquisition of Convergent Genomics for $150M upfront plus up to $30M in milestone payments. Convergent brings UroAmp and proprietary urine tumor DNA technology focused on bladder cancer diagnostics to Veracyte's portfolio.
Bally's secured $560M in senior secured term loans ($400M closing + $160M delayed draw) from WhiteHawk Capital Partners to fund pre-construction costs for the Bronx casino project and general corporate purposes. Financing expected to close Q3 2026 subject to regulatory approval.
Addus HomeCare agreed to acquire AccentCare's personal care and community care business outside New York for $275 million in cash. The transaction includes 10 operating entities across multiple states and certain assets, subject to regulatory approvals and Hart-Scott-Rodino clearance.
Kestra reported Q1 FY2027 revenue of $31.0M (+60% YoY) with gross margin expansion to 56.5% from 45.7%. FY27 revenue guidance raised to $141M (+48% growth). Strong execution on WCD market expansion and commercial initiatives.
HealthStream amended its revolving credit facility with Truist Bank. The $50M facility matures in 2031 with unchanged terms, including a 3.00x net funded debt leverage covenant and 3.00x interest coverage ratio requirement.
Oklo entered into a new $1B equity distribution agreement with 10 sales agents for at-the-market offerings. Simultaneously terminated prior $1B ATM program after selling ~$1B in shares. No net change in authorized capital raising capacity.
Cronos amended its share purchase agreement for CanAdelaar B.V. acquisition, extending the Long Stop Date from September 9, 2026 to October 15, 2026. No material terms altered; administrative extension only.
8-K · Items 2.01, 3.01, 3.03, 5.01, 5.02 — Acquisition or disposal of assets
AtaiBeckley Inc. completed its merger with Eli Lilly on September 11, 2026. Shareholders received $6.75 per share in cash plus contingent value rights tied to clinical and regulatory milestones for two drug candidates (VLS-01, BPL-003) over 7 years.
Centrus completed a $500M underwritten offering of common stock and warrants. Company is in advanced discussions to acquire a domestic manufacturing supplier for $115–125M, targeting vertical integration and supply chain enhancement.
OCSL entered into underwriting agreement to issue $300M of 7.000% Notes due 2031, with net proceeds of $296.5M. Closing expected September 16, 2026. Represents material capital raise for the specialty lending company.
SI-BONE initiated a voluntary Class II recall of 98 iFuse TORQ implants due to tube packaging sterile barrier failure. Approximately 3,900 total implants require repackaging. Expected gross charge of up to $150,000 in Q3/Q4 COGS. Two implants already implanted; no adverse events reported to date.
Hagerty's selling stockholder completed a secondary offering of 10.6M shares at $11.95/share. The offering was fully underwritten by Wells Fargo and J.P. Morgan. No direct impact on company operations or fundamentals disclosed.
Trustmark Bank sold 34 branch properties to Blue Owl for $91.7M, generating a $61.5M pre-tax gain, then leased them back under 15-year terms with 1.5% annual escalation. Concurrently, the company offset this gain by selling $629.9M of lower-yielding securities and purchasing $628.0M of higher-yielding securities, resulting in a $61.5M pre-tax loss.
Bank7 Corp. won a court-supervised auction for ~71% of Century Financial Services Corporation, increasing purchase price from $68.0M to $88.96M. Closing remains subject to court approval and Federal Reserve regulatory clearance.
IBEX reported record FY2026 revenue of $644.1M (+15.4% YoY), net income of $46.3M (+25.7%), and adjusted EPS of $3.52 (+28.3%). Extended credit facilities to October 2029. Provided FY2027 guidance of $700-715M revenue (+9-11%) and $90-94M adjusted EBITDA (+9-14%).
MYR Group refinanced its credit facility, increasing revolving capacity from $490M to $690M and securing a five-year term loan. The expanded facility supports working capital, acquisitions, and general corporate purposes with improved financial flexibility.
Principal stockholder Ingram Holdco, LLC (Platinum Equity affiliate) conducted secondary offering of 13.125M shares at $27.25/share. Company repurchased 625K shares from underwriter using existing $175M program, leaving $53M capacity.
AAOI exercised a purchase option to acquire a 153,928 sq ft facility in Houston for $26.78M cash on September 4, 2026. Property will be used for office, warehouse, light manufacturing and assembly purposes.
ACV Auctions entered into a definitive merger agreement with Copart Inc. on September 10, 2026. Copart will acquire all outstanding ACV shares via tender offer at $10.50 per share in cash, representing a material transaction with significant strategic implications for ACV shareholders.
Axogen announced definitive agreement to acquire BioCircuit Technologies for $200M cash. BioCircuit's NerveTape is FDA-approved sutureless nerve repair device. Transaction expected Q4 2026; anticipated accretive to revenue growth, adjusted EBITDA margin, and adjusted EPS in year one while maintaining positive free cash flow.
Chemours, DuPont, and Corteva settled PFAS-related claims with North Carolina and 11 local entities for $455 million over 15 years. Chemours' 50% share (~$180 million actual, $210 million NPV) is covered by existing accruals. Settlement resolves litigation and acknowledges progress under 2019 Consent Order.
Cooper-Standard amended its ABL facility, increasing commitments by $20M to $200M total, extending maturity to September 2031, and reducing borrowing margins by 50-100 basis points while removing credit spread adjustments.
As stated in the filing: “Wesbanco, Inc. issued a press release announcing that the Company's financial results for the third quarter of 2026 will be released after the market close on Wednesday, October 21, 2026.”
As stated in the filing: “…Columbia Banking System, Inc. (“Columbia” Nasdaq: COLB), parent company of Columbia Bank, today announced it will release third quarter 2026 financial results on Thursday, October 22, 2026, after market close.”
As stated in the filing: “On October 5, 2026 , Broadstone Net Lease, Inc. (the “Company”) issued a press release announcing that it will release its financial and operating results for the quarter ended September 30, 2026 after the market closes on Wednesday, October 28, 2026.”
As stated in the filing: “Pebblebrook Hotel Trust (the "Company") announced on September 11, 2026 that it will report its financial and operating results for the quarter ending September 30, 2026, on Thursday, October 29, 2026, after the market closes.”
As stated in the filing: “…On September 29, 2026, we announced we will release our third quarter 2026 financial results after the market closes on Monday, November 2, 2026, and will host a conference call at 11 a.m. Eastern Standard Time (10 a.m. Central Standard Time) on Tuesday, November 3, 2026.”
As stated in the filing: “UMH’s final third quarter results will be released on Monday, November 2, 2026, after the close of trading on the New York Stock Exchange and will be available on the Company’s website at www.umh.reit , in the Financials section.”
As stated in the filing: “…On October 1, 2026, Blue Owl Capital Corporation (the “Company”) issued a press release to announce that the Company will release its financial results for the third quarter ended September 30, 2026 on Wednesday, November 4, 2026 after market close.”
As stated in the filing: “…On October 1, 2026, Blue Owl Technology Finance Corp. (the “Company”) issued a press release to announce that the Company will release its financial results for the third quarter ended September 30, 2026 on Wednesday, November 4, 2026 after market close.”
As stated in the filing: “…CION Investment Corporation (NYSE: CION) (“CION”) announced today that it will report its financial results for the third quarter ended September 30, 2026 on Thursday, November 5, 2026, prior to the opening of the financial markets.”
As stated in the filing: “On October 5, 2026, Goldman Sachs BDC, Inc. (the “Company”) issued a press release announcing that it will report its third quarter ended September 30, 2026 financial results after the market closes on Thursday, November 5, 2026, and that it will host an earnings conference call on Friday, November 6, 2026 at 9:00 am Eastern Time to discuss its financial results.”
As stated in the filing: “On September 24, 2026, ICF International, Inc. (the “Company”) announced it will release its third quarter 2026 earnings results after the market closes on Thursday, November 5, 2026.”